-
Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program
28 May 2025 12:46 GMT
Geron Corporation (Nasdaq: GERN), a … patients regardless of prior treatment with luspatercept or lenalidomide. … levels, or their treatment history; (iv) Geron’s beliefs that the … Geron is successful in commercializing RYTELO (imetelstat) for the treatment …
-
Geron Corp. Posts Narrower Loss In Q1
07 May 2025 19:15 GMT
Geron Corp. (GERN) posted a first quarter … .
As of March 31, 2025, Geron had approximately $457.5 million …
-
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19 May 2025 20:26 GMT
Geron Corporation (Nasdaq: GERN), a commercial … to continued employment with Geron through the applicable vesting dates … under the plan.
About Geron
Geron is a commercial-stage biopharmaceutical … the European Union for the treatment of certain adult patients …
-
Is Geron Corp. (NASDAQ:GERN) the Most Promising Penny Stock According to Analysts?
18 Apr 2025 16:01 GMT
… see more details here). Is Geron Corp. (NASDAQ:GERN) the Most … telomerase inhibitor for the treatment of adult patients with … received a Category 1 treatment recommendation for second-line … Hims & Hers and Geron Corporation (NASDAQ:GERN). Overall, GERN …
-
GERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
16 May 2025 01:00 GMT
… is investigating potential claims against Geron Corporation (NASDAQ: GERN) on behalf … board of directors of Geron have breached their fiduciary … other things, confidence in Geron's ability to … a long-term stockholder of Geron, have information, would …
-
Geron Corporation Investors: Please contact the Portnoy Law Firm to recover your losses. May 12 2025 Deadline to file Lead Plaintiff Motion.
12 May 2025 22:10 GMT
… The Portnoy Law Firm advises Geron Corporation ("Geron" or the … they possessed reliable information regarding Geron’s projected revenue outlook and … to achieve meaningful penetration, preventing Geron from capitalizing on the purportedly …
-
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron
12 May 2025 17:56 GMT
… is investigating potential claims against Geron Corporation (“Geron” or the “Company”) ( … February 26, 2025, Geron announced its financial results … drug treatment.
Following this news, the price of Geron’ … anyone with information regarding Geron’s conduct to …
-
The Gross Law Firm Notifies Shareholders of Geron Corporation(GERN) of a Class Action Lawsuit and an Upcoming Deadline
12 May 2025 17:12 GMT
… following notice to shareholders of Geron Corporation (NASDAQ: GERN). Shareholders who purchased … ;securitiesclasslaw.com/securities/geron-corporation-loss-submission-form/?id … the drug treatment. Following this news, the price of Geron’s common …
-
Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025 - GERN
11 May 2025 12:17 GMT
… is investigating potential claims against Geron Corporation (“Geron” or the “Company”) ( … February 26, 2025, Geron announced its financial results … drug treatment. Following this news, the price of Geron’ … anyone with information regarding Geron’s conduct to …
-
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Geron Corporation and Certain Officers – GERN
09 May 2025 12:00 GMT
… lawsuit has been filed against Geron Corporation (“Geron” or the “Company”) (NASDAQ: … commercialization of therapeutics for the treatment of cancer and chronic … or high-risk myelofibrosis. Geron categorizes treatment eligible patients with lower-risk …
About
© 1995-2025